Lotepred LS Eye Drop contains Loteprednol etabonate 0.2% w/v, a corticosteroid indicated for the treatment of inflammatory conditions of the eye, including allergic conjunctivitis, postoperative inflammation, and other corticosteroid-responsive ocular disorders. Loteprednol etabonate is a soft steroid designed to provide potent anti-inflammatory effects with a reduced risk of steroid-related side effects such as elevated intraocular pressure. The formulation acts by inhibiting the release of inflammatory mediators, thereby reducing redness, swelling, and irritation. Lotepred LS Eye Drop is typically administered as one to two drops in the affected eye(s) two to four times daily, with dosage adjustments based on clinical response. It is contraindicated in patients with active ocular infections caused by bacteria, fungi, or viruses, and should be used cautiously in individuals with glaucoma or a history of steroid-induced ocular hypertension. Patients should be advised not to discontinue therapy abruptly and to adhere to prescribed dosing to prevent rebound inflammation. Regular monitoring by an ophthalmologist is recommended to assess therapeutic efficacy and detect potential adverse effects. Lotepred LS Eye Drop offers an effective and well-tolerated option for managing ocular inflammation with a favorable safety profile.